Fixes Book Closure for Dividend & A G M
Lincoln Pharmaceuticals Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2013 to September 30, 2013 (both days inclusive) for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company. Results Press Release
Lincoln Pharmaceuticals Ltd has submitted to BSE a copy of Results Press Release for the period ended March 31, 2013. Board recommends Dividend
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2013, inter alia, has recommended the payment of Dividend of Rs. 0.60 (@ 6%) per equity share of f.v. Rs. 10/- each of the Company. Financial Results for March 31, 2013 (Audited)
Lincoln Pharmaceuticals Ltd has informed BSE about the Financial Results for the period ended March 31, 2013. Board to consider Dividend
Lincoln Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2013, to approve audited financial result for the quarter/year ended March 31, 2013 and for recommending dividend, if any. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Munjal Mahendrabhai Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Lincoln Pharmaceuticals Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Hasmukhbhai Ishwarlal Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Ashish Rajnibhai Patel has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011